FDA issues emergency use authorization of convalescent plasma for COVID-19

President Trump on Sunday announced that the Food and Drug Administration has issued an emergency use authorization for the use of convalescent plasma for COVID-19 patients.
The FDA said more than 70,000 patients have been treated with convalescent plasma, which is taken from people who have recovered from COVID-19, and the "known and potential benefits of the product outweigh the known and potential risks of the product." Trump called the move "historic" and claimed the treatment will "save countless lives."
There is no conclusive evidence that using convalescent plasma works, and Denise Hinton, the FDA's chief scientist, said this "should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Trump, who has touted the use of everything from disinfectants to antimalarial drugs to treat COVID-19, recently accused the FDA of "making it very difficult for drug companies to get people in order to test the vaccines and therapeutics." Benjamin Corb of the American Society for Biochemistry and Molecular Biology told The Associated Press Trump's Sunday announcement has "conspicuous timing. President Trump is once against putting his political goals ahead of the health and well-being of the American public."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Why are Europe's leaders raising red flags about Trump's Ukraine overtures to Putin?
TODAY'S BIG QUESTION Officials from across the continent warn that any peace plan without their input is doomed from the start
By Rafi Schwartz, The Week US Published
-
Cozy video games to unwind from the chaos
The Week Recommends Some games can go a long way in alleviating stress or anxiety
By Theara Coleman, The Week US Published
-
Elon Musk and Wikipedia are feuding
The Explainer The online encyclopedia stands accused of being far-left propaganda
By Devika Rao, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published